Glutathionylation Mediates Angiotensin II–Induced eNOS Uncoupling, Amplifying NADPH Oxidase‐Dependent Endothelial Dysfunction

Background Glutathionylation of endothelial nitric oxide synthase (eNOS) “uncouples” the enzyme, switching its function from nitric oxide (NO) to O2•− generation. We examined whether this reversible redox modification plays a role in angiotensin II (Ang II)‐induced endothelial dysfunction. Methods and Results Ang II increased eNOS glutathionylation in cultured human umbilical vein endothelial cells (HUVECs), rabbit aorta, and human arteries in vitro. This was associated with decreased NO bioavailability and eNOS activity as well as increased O2•− generation. Ang II‐induced decrease in eNOS activity was mediated by glutathionylation, as shown by restoration of function by glutaredoxin‐1. Moreover, Ang II‐induced increase in O2•− and decrease in NO were abolished in HUVECs transiently transfected, with mutant eNOS rendered resistant to glutathionylation. Ang II effects were nicotinamide adenine dinucleotide phosphate (NADPH) oxidase dependent because preincubation with gp 91ds‐tat, an inhibitor of NADPH oxidase, abolished the increase in eNOS glutathionylation and loss of eNOS activity. Functional significance of glutathionylation in intact vessels was supported by Ang II‐induced impairment of endothelium‐dependent vasorelaxation that was abolished by the disulfide reducing agent, dithiothreitol. Furthermore, attenuation of Ang II signaling in vivo by administration of an angiotensin converting enzyme (ACE) inhibitor reduced eNOS glutathionylation, increased NO, diminished O2•−, improved endothelium‐dependent vasorelaxation and reduced blood pressure. Conclusions Uncoupling of eNOS by glutathionylation is a key mediator of Ang II‐induced endothelial dysfunction, and its reversal is a mechanism for cardiovascular protection by ACE inhibition. We suggest that Ang II‐induced O2•− generation in endothelial cells, although dependent on NADPH oxidase, is amplified by glutathionylation‐dependent eNOS uncoupling.

[1]  N. Toda,et al.  Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation , 2007, Pharmacological Reviews.

[2]  M. Gallogly,et al.  Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. , 2007, Current opinion in pharmacology.

[3]  B. Babior.  The activity of leukocyte NADPH oxidase: regulation by p47PHOX cysteine and serine residues. , 2002, Antioxidants & redox signaling.

[4]  M. Watkins,et al.  S-glutathionylation uncouples eNOS and regulates its cellular and vascular function , 2011 .

[5]  D. Harrison,et al.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.

[6]  S. Snyder,et al.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase , 1991, Nature.

[7]  G. Figtree,et al.  Reversible Oxidative Modification: A Key Mechanism of Na+-K+ Pump Regulation , 2009, Circulation research.

[8]  T. Rabelink,et al.  Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. , 1997, Biochemical and biophysical research communications.

[9]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[10]  R. Stocker,et al.  Improved analysis of hydroethidine and 2-hydroxyethidium by HPLC and electrochemical detection. , 2007, Free Radical Biology & Medicine.

[11]  L. Juncos,et al.  Effects of Captopril on the Renin Angiotensin System, Oxidative Stress, and Endothelin in Normal and Hypertensive Rats , 2005, Hypertension.

[12]  J. Zweier,et al.  Redox modulation of endothelial nitric oxide synthase by glutaredoxin-1 through reversible oxidative post-translational modification. , 2013, Biochemistry.

[13]  J. Zweier,et al.  Superoxide Induces Endothelial Nitric-oxide Synthase Protein Thiyl Radical Formation, a Novel Mechanism Regulating eNOS Function and Coupling* , 2011, The Journal of Biological Chemistry.

[14]  U. Förstermann,et al.  Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats. , 2006, Journal of the American College of Cardiology.

[15]  U. Walter,et al.  Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling , 2002, Circulation research.

[16]  B. Kalyanaraman,et al.  Detection of 2-hydroxyethidium in cellular systems: a unique marker product of superoxide and hydroethidine , 2007, Nature Protocols.

[17]  T. Münzel,et al.  Vascular Dysfunction in Experimental Diabetes Is Improved by Pentaerithrityl Tetranitrate but Not Isosorbide-5-Mononitrate Therapy , 2011, Diabetes.

[18]  D. Harrison,et al.  Sad heart from no SOD. , 2008, Hypertension.

[19]  A. Hale,et al.  Integrated Redox Sensor and Effector Functions for Tetrahydrobiopterin- and Glutathionylation-dependent Endothelial Nitric-oxide Synthase Uncoupling* , 2012, The Journal of Biological Chemistry.

[20]  I. Chetter,et al.  Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials. , 2011, Atherosclerosis.

[21]  K. Anderson,et al.  An introduction to methods for analyzing thiols and disulfides: Reactions, reagents, and practical considerations. , 2009, Analytical biochemistry.

[22]  G. Figtree,et al.  Oxidative inhibition of the vascular Na+-K+ pump via NADPH oxidase-dependent β1-subunit glutathionylation: implications for angiotensin II-induced vascular dysfunction. , 2013, Free radical biology & medicine.

[23]  Jay L Zweier,et al.  S-glutathionylation reshapes our understanding of endothelial nitric oxide synthase uncoupling and nitric oxide/reactive oxygen species-mediated signaling. , 2011, Antioxidants & redox signaling.

[24]  A. Herman,et al.  Effect of Hypercholesterolemia on Vascular Reactivity in the Rabbit. II. Influence of Treatment With Dipyridamole on Endothelium-Dependent and Endothelium‐Independent Responses in Isolated Aortas of Control and Hypercholesterolemic Rabbits , 1986, Circulation research.

[25]  J. Probstfield,et al.  Progression of cardiovascular damage: the role of renin-angiotensin system blockade. , 2010, The American journal of cardiology.

[26]  T. Münzel,et al.  Nitroglycerin-Induced Endothelial Dysfunction and Tolerance Involve Adverse Phosphorylation and S-Glutathionylation of Endothelial Nitric Oxide Synthase: Beneficial Effects of Therapy With the AT1 Receptor Blocker Telmisartan , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[27]  T. Takemasa,et al.  Detection of intracellular nitric oxide using a combination of aldehyde fixatives with 4,5-diaminofluorescein diacetate , 2000, Histochemistry and Cell Biology.

[28]  M. Wheeler,et al.  Functional nitric oxide synthase mislocalization in cardiomyopathy. , 2004, Journal of molecular and cellular cardiology.

[29]  D. Pimentel,et al.  S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide , 2004, Nature Medicine.

[30]  C. Hidalgo,et al.  Tachycardia increases NADPH oxidase activity and RyR2 S-glutathionylation in ventricular muscle. , 2005, Journal of molecular and cellular cardiology.

[31]  P. Oster,et al.  Active and Passive Immunization Against Angiotensin II in the Rat and Rabbit: EVIDENCE FOR A NORMAL REGULATION OF THE RENIN-ANGIOTENSIN SYSTEM , 1975, Circulation research.

[32]  I. Fridovich,et al.  The effects of superoxide dismutase on H2O2 formation. , 2007, Free radical biology & medicine.

[33]  D. Harrison,et al.  Spin trapping of vascular nitric oxide using colloid Fe(II)-diethyldithiocarbamate. , 2000, Biochemical and biophysical research communications.

[34]  D. Harrison,et al.  Vascular NADPH oxidases as drug targets for novel antioxidant strategies. , 2006, Drug discovery today.

[35]  J. Youn,et al.  The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes , 2012, Diabetologia.

[36]  P. Witting,et al.  The smoking-associated oxidant hypothiocyanous acid induces endothelial nitric oxide synthase dysfunction. , 2014, The Biochemical journal.

[37]  J. Balligand,et al.  Moderate Caveolin-1 Downregulation Prevents NADPH Oxidase–Dependent Endothelial Nitric Oxide Synthase Uncoupling by Angiotensin II in Endothelial Cells , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[38]  D. Townsend,et al.  Diazeniumdiolate Mediated Nitrosative Stress Alters Nitric Oxide Homeostasis through Intracellular Calcium and S-Glutathionylation of Nitric Oxide Synthetase , 2010, PloS one.